Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.
Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6361-6366. doi: 10.26355/eurrev_202209_29662.
To explore the clinical value of high mobility group box-1 (HMGB-1), C-reactive protein (CRP), procalcitonin (PCT), and CRP to albumin (Alb) ratio in the diagnosis and evaluation of the severity of sepsis in children.
A total of 90 children, 50 with sepsis and 40 with general infection, whose symptoms did not meet the criteria for diagnosis of sepsis, were admitted to the Pediatrics Department of Jingzhou Central Hospital in Hubei Province between November 2021 and December 2022, were enrolled and selected as experimental and control group, respectively. The serum of two groups was collected within 24 hours after admission, the levels of HMGB-1 were detected by enzyme-linked immunosorbent assay (ELISA), and CRP, PCT, Alb, and hospitalization days were recorded. The differences in indicators between the two groups were compared, and correlation analysis was performed between hospitalization days and various indicators. The receiver operating characteristic (ROC) curve was drawn to evaluate the independent or combined value of CRP, PCT, HMGB-1, and CRP/Alb ratio in the early diagnosis of sepsis in children.
These four indicators of children with sepsis were significantly higher than those in the general infection group (all p=0.000). The levels of CRP, PCT and CRP/Alb ratio were significantly positively correlated with the hospitalization days (r=0.329, 0.333, 0.329; p=0.02, 0.01, 0.002). The area under curve (AUC) of CRP, PCT, HMGB-1, and CRP/Alb ratio for the diagnosis of sepsis in children was 0.798, 0.817, 0.838, 0.809, respectively, and that of the combination of four indicators was 0.952.
CRP, PCT, HMGB-1, and CRP/Alb ratio resulted as effective indicators for early diagnosis and evaluation of childhood sepsis, having a higher value in combined diagnosis.
探讨高迁移率族蛋白 B1(HMGB-1)、C 反应蛋白(CRP)、降钙素原(PCT)及 CRP 与白蛋白(Alb)比值在儿童脓毒症诊断及严重程度评估中的临床价值。
选取 2021 年 11 月至 2022 年 12 月湖北省荆州市中心医院儿科收治的 90 例患儿,其中脓毒症患儿 50 例,非脓毒症感染患儿 40 例。患儿入院后 24 h 内采集两组患儿的血清,采用酶联免疫吸附试验(ELISA)检测 HMGB-1 水平,记录 CRP、PCT、Alb 及住院天数。比较两组患儿各指标的差异,并对住院天数与各指标进行相关性分析。绘制受试者工作特征(ROC)曲线,评估 CRP、PCT、HMGB-1 及 CRP/Alb 比值对儿童脓毒症早期诊断的独立或联合价值。
脓毒症患儿的这四项指标均显著高于非脓毒症感染组(均 P=0.000)。CRP、PCT 及 CRP/Alb 比值与住院天数均呈显著正相关(r=0.329、0.333、0.329;P=0.02、0.01、0.002)。CRP、PCT、HMGB-1 及 CRP/Alb 比值对儿童脓毒症的诊断 AUC 分别为 0.798、0.817、0.838、0.809,四项联合诊断的 AUC 为 0.952。
CRP、PCT、HMGB-1、CRP/Alb 比值均可作为儿童脓毒症早期诊断及严重程度评估的有效指标,联合诊断具有更高的价值。